Webb27 maj 2024 · Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW:FSE), a Canada-based clinical stage drug development company that focuses on drug … Webb22 juni 2024 · Mergers and acquisitions of small-cap biopharma companies may be poised to accelerate. Big Pharma is flush with COVID-19 vaccine cash that could be deployed in …
Small Cap U.S. Pharmaceuticals & Biotech Stocks by Market Cap
Webb21 dec. 2024 · Rocket Pharmaceuticals. Market value: $1.75 billion. Analysts' consensus recommendation: 1.20 (Strong Buy) Rocket Pharmaceuticals ( RCKT) is another small … Webb3 sep. 2024 · Vanda Pharmaceuticals Inc. VNDA is a Washington, D.C.-based biopharmaceutical company that focuses on developing and commercializing a portfolio of clinical-stage, small molecule product candidates for central nervous system disorders. The company’s famous products are HETLIOZ and Fanapt. It has a $926.38 million … dickens real estate - bright
Smallcap
Webb6 jan. 2024 · With a market capitalization (cap) of 47.8 million, Novocure is a small company whose shares are volatile. In fact, 2024 has not been a good year for investors. … Webb29 aug. 2024 · Rare disease is becoming an increasing area of focus in the pharmaceutical industry, with a market size estimated to reach $169B by 2024. Defined in the US as conditions affecting fewer than 200,000 people, rare diseases range from brain disorders to diseases affecting the skin, kidneys, and lungs. Webb21 dec. 2024 · Rocket Pharmaceuticals Market value: $1.75 billion Analysts' consensus recommendation: 1.20 (Strong Buy) Rocket Pharmaceuticals () is another small-cap biotech with promising drugs under development, and it currently tops the list of Wall Street's favorite small-cap stocks to buy now. dickens quote best of times